Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous IL-2 and Interferon Alfa in Metastatic Renal Cell Carcinoma
NCT00002847Phase 2Unknown
- Sponsor
- Levine Cancer Institute
- Start
- Sep 1995
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin, interferon alfa in renal cell carcinoma (RCC), sponsored by Levine Cancer Institute. Status: unknown.
02
Drugs
aldesleukininterferon alfa
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00002847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002847.